{"rows":[{"id":5941,"title":"A Case of Acute Mania and Rhabdomyolysis Associated With Long-Term, Daily Psilocybin Use.","authors":"Wells DA, Hayes L, Walker K.","journal":"Journal of clinical psychopharmacology","publication_date":"2026-09-21","publication_year":2026,"doi":"10.1097/jcp.0000000000002262","pubmed_id":"42758023","openalex_id":"https://openalex.org/W7213536713","source_url":"https://doi.org/10.1097/jcp.0000000000002262","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-19 01:20:18","last_checked":"2026-09-28 01:20:25","bibtex":null,"source_record_id":"PMID:42758023","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42758023","source_url":"https://doi.org/10.1097/jcp.0000000000002262","doi":"10.1097/jcp.0000000000002262","pmid":"42758023","publication_date":"2026-09-21","importer_version":"2.1.3","text_redistributed":false}},{"id":2767,"title":"Serotonin, psilocybin, and body dysmorphic disorder: a case report.","authors":"Hanes KR","journal":"Journal of clinical psychopharmacology","publication_date":"1996-04-01","publication_year":1996,"doi":"10.1097/00004714-199604000-00011","pubmed_id":"8690834","openalex_id":"https://openalex.org/W2092586569","source_url":"https://pubmed.ncbi.nlm.nih.gov/8690834/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Case Report","study_type":"Case Report","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:30","bibtex":null,"source_record_id":"PMID:8690834","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/8690834/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:8690834","source_url":"https://pubmed.ncbi.nlm.nih.gov/8690834/","doi":"10.1097/00004714-199604000-00011","pmid":"8690834","publication_date":"1996-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2156,"title":"Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.","authors":"Rocha JM, Rossi GN, de Lima Osório F, Bouso JC, de Oliveira Silveira G, Yonamine M, Campos AC, Bertozi G, Cecílio Hallak JE, Dos Santos RG","journal":"Journal of clinical psychopharmacology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.1097/jcp.0000000000001396","pubmed_id":"33843820","openalex_id":"https://openalex.org/W3154361912","source_url":"https://pubmed.ncbi.nlm.nih.gov/33843820/","substance_tags":"psilocybin","topic_tags":"Anxiety,Wellbeing,Emotional Processing,Randomized Controlled Trial,Healthy Volunteers,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:33843820","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33843820/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33843820","source_url":"https://pubmed.ncbi.nlm.nih.gov/33843820/","doi":"10.1097/jcp.0000000000001396","pmid":"33843820","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1649,"title":"A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.","authors":"Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI","journal":"Journal of clinical psychopharmacology","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1097/jcp.0000000000001608","pubmed_id":"36193898","openalex_id":"https://openalex.org/W4301392523","source_url":"https://pubmed.ncbi.nlm.nih.gov/36193898/","substance_tags":"psilocybin","topic_tags":"Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36193898","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36193898/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36193898","source_url":"https://pubmed.ncbi.nlm.nih.gov/36193898/","doi":"10.1097/jcp.0000000000001608","pmid":"36193898","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1648,"title":"Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.","authors":"Balon R","journal":"Journal of clinical psychopharmacology","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1097/jcp.0000000000001610","pubmed_id":"36251379","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36251379/","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36251379","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36251379","source_url":"https://pubmed.ncbi.nlm.nih.gov/36251379/","doi":"10.1097/jcp.0000000000001610","pmid":"36251379","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":534,"title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.","authors":"Ludbrook G, Bryson N, Taylor B, Hocevar-Trnka J, Johnson MW, Hirman J, Morrish G, Alexander R, Pollack M","journal":"Journal of clinical psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1097/jcp.0000000000002047","pubmed_id":"40685873","openalex_id":"https://openalex.org/W4412513351","source_url":"https://pubmed.ncbi.nlm.nih.gov/40685873/","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Pharmacology,Mystical Experience,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40685873","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40685873/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40685873","source_url":"https://pubmed.ncbi.nlm.nih.gov/40685873/","doi":"10.1097/jcp.0000000000002047","pmid":"40685873","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":455,"title":"Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.","authors":"Havlik JL, Isaac S, Raman P, Tran N, Hidalgo K, Suppes T","journal":"Journal of clinical psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1097/jcp.0000000000002095","pubmed_id":"40994136","openalex_id":"https://openalex.org/W4414528095","source_url":"https://pubmed.ncbi.nlm.nih.gov/40994136/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,Emotional Processing,Clinical Trial,Toxicity","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:40994136","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40994136/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40994136","source_url":"https://pubmed.ncbi.nlm.nih.gov/40994136/","doi":"10.1097/jcp.0000000000002095","pmid":"40994136","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":256,"title":"The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.","authors":"Kirlić N, Atli M, Mistry S, Gold M, Goodwin GM","journal":"Journal of clinical psychopharmacology","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1097/jcp.0000000000002119","pubmed_id":"41362124","openalex_id":"https://openalex.org/W4417148678","source_url":"https://pubmed.ncbi.nlm.nih.gov/41362124/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Consciousness,Personality Change,Emotional Processing,Treatment-Resistant Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41362124","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41362124/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41362124","source_url":"https://pubmed.ncbi.nlm.nih.gov/41362124/","doi":"10.1097/jcp.0000000000002119","pmid":"41362124","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":6,"title":"Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.","authors":"Kervadec E, Bezo A, Serreau R, Strika-Bruneau L, Fauvel B, Amirouche A, Benyamina A, Romeo B","journal":"Journal of clinical psychopharmacology","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1097/jcp.0000000000002197","pubmed_id":"42228481","openalex_id":"https://openalex.org/W7163126953","source_url":"https://pubmed.ncbi.nlm.nih.gov/42228481/","substance_tags":"psilocybin","topic_tags":"PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study,Safety,Adverse Events,Toxicity","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:42228481","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42228481/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42228481","source_url":"https://pubmed.ncbi.nlm.nih.gov/42228481/","doi":"10.1097/jcp.0000000000002197","pmid":"42228481","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":9,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Journal of clinical psychopharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}